Although current data argue against an increased risk of pancreatic cancer and thyroid cancer with semaglutide, it can be debated whether the background incidence of these disorders is too low to fully conclude the absence of an association
A 2023 study out of the University of British Columbia linked GLP-1 agonists to a heightened risk of severe gastrointestinal problems. These problems include gastroparesis, pancreatitis, and bowel obstruction
Her approach is rooted in evidence-based treatments that are both safe and effective, emphasizing long-term health and wellness
I found it very surprising that similar micro-RNA in human sperm also seems to be necessary for embryo development," says Anita st
Watching for serious side effects, like thyroid tumors or gallbladder trouble, is needed
Its essential to communicate fatigue and any other side effects to your healthcare provider